“Advancing Translational Sciences Through Multi-Disease Platforms and Technologies”
Thursday, September 2 at 12:00pm
This is a past event.
Part of the USC/CHLA Cell Therapy Program Seminar Series
Marc Ferrer, Ph.D.
Director, 3-D Tissue Bioprinting Laboratory
Division of Preclinical Innovation
Early Translation Branch
National Center for Advancing Translational Sciences
Learn more about :
- NCATS advances translational sciences through collaborative research.
- NCATS builds translational platforms and technologies to address multiple diseases at a time.
- NCATS uses engineered tissues as a technology platform for disease modeling and drug screening